University of Vermont

UVM ScholarWorks
UVM Honors College Senior Theses

Undergraduate Theses

2017

An Investigation Into The Mechanism Of Cysteine-containing
Thioredoxin Reductases: How Is Catalysis Conserved Without The
Presence Of A Selenocysteine Residue?
Neil C. Payne
University of Vermont

Follow this and additional works at: https://scholarworks.uvm.edu/hcoltheses

Recommended Citation
Payne, Neil C., "An Investigation Into The Mechanism Of Cysteine-containing Thioredoxin Reductases:
How Is Catalysis Conserved Without The Presence Of A Selenocysteine Residue?" (2017). UVM Honors
College Senior Theses. 164.
https://scholarworks.uvm.edu/hcoltheses/164

This Honors College Thesis is brought to you for free and open access by the Undergraduate Theses at UVM
ScholarWorks. It has been accepted for inclusion in UVM Honors College Senior Theses by an authorized
administrator of UVM ScholarWorks. For more information, please contact scholarworks@uvm.edu.

AN INVESTIGATION INTO THE MECHANISM OF CYSTEINE-CONTAINING
THIOREDOXIN REDUCTASES: HOW IS CATALYSIS CONSERVED WITHOUT
THE PRESENCE OF A SELENOCYSTEINE RESIDUE?

A Dissertation Presented
by
Neil Connor Payne
to
The Faculty of the College of Arts and Sciences
of
The University of Vermont

In Partial Fulfillment of the Requirements
For the Degree of Bachelor of Science
Specializing in Chemistry
April, 2017

Defense Date: April 27, 2017
Dissertation Examination Committee:
Robert J. Hondal, Ph.D., Advisor
Jay Silveira, Ph.D., Chair
Jose S. Madalengoitia, Ph.D.

Abstract

Thiorexodin reductase (TrxR) plays a major role in maintaining cellular
antioxidant homeostasis. Mammalian TrxR (mTrxR) is defined by its rare, penultimate
amino acid selenocysteine (Sec), which is essential to enzyme catalysis. However, some
forms of TrxR in nature do not utilize Sec. One form of TrxR that does not use Sec is
mitochondrial TrxR from C. elegans (CeTrxR2). Despite not possessing a Sec residue,
CeTrxR2 maintains similar catalytic activity to mTrxR. It has been hypothesized that
these Cys-containing TrxRs must somehow activate their active site C-terminal vicinal
disulfide bond to achieve catalytic activity comparable to Sec-containing TrxRs, which
instead contain a C-terminal vicinal selenosulfide bond. In order to further the
understanding of how Cys-containing TrxRs maintain catalytic activity without the
presence of Sec, we studied the mechanism of CeTrxR2 by synthesizing a mutant peptide
substrate, whose activity towards a truncated form of CeTrxR2 was measured and
compared with the wild-type peptide substrate. Our results provide evidence that a crucial
hydrogen bond in the enzyme active site induces type VIa beta-turn formation, which
places amino acid residues in the correct position for catalysis.

2

Dedication

To my Father and Mother, who have provided the most gracious support for me
throughout not only my college years, but my entire life. I have and will continue to learn
so much from both of you. Thank you for everything that you do.

3

Table of Contents

Abstract.............................................................................................................................. 2
Dedication .......................................................................................................................... 3
Table of Contents .............................................................................................................. 4
List of Figures.................................................................................................................... 6
List of Schemes .................................................................................................................. 7
Chapter 1: Thioredoxin Reductase ................................................................................. 8
1.1 Introduction ........................................................................................................................... 8
1.2 Previous Work Towards Understanding Cys-Containing TrxRs ........................................ 13
1.3 Hypothesis: A Key Hydrogen Bond and Vicinal Disulfide Ring Conformation are Essential
to CeTrxR Catalytic Activity ..................................................................................................... 22
1.4 Plan to Test this Hypothesis ................................................................................................ 27
1.5 Retrosynthetic Analysis of Depsipeptide PRTQGCC(Gac) ................................................ 29

Chapter 2: Synthesis of Wild-Type and Mutant Peptides Corresponding to the CTerminal Active Site of CeTrxR .................................................................................... 31
2.1 Synthesis of Fmoc-Protected Cys(Mob)-Glycolic Acid Depside for Solid Phase
Depsipeptide Synthesis .............................................................................................................. 31
2.2 Synthesis of Mutant Depsipeptide 8-mer PRTQGCC(Gac) Corresponding to the C-terminal
Active Site of CeTrxR ............................................................................................................... 33
2.3 Synthesis of Wild Type Peptide 8-mer PRTQGCCG Corresponding to the C-terminal
Active Site of CeTrxR ............................................................................................................... 34

4

Chapter 3: Activity of Wild-Type and Mutant Peptide Substrates Towards
Reduction by the N-terminal Redox Center of CeTrxRD8 ......................................... 35
3.1 Characterization and Assessment of Purity of PRTQGCCG and PRTQGCC(Gac)
Substrates ................................................................................................................................... 35
3.2 Activity of Substrates Towards Reduction by CeTrxRD8 .................................................. 41

Chapter 4: Summary and Future Directions ............................................................... 44
Chapter 5: Experimental Procedures ........................................................................... 45
5.1 Materials and Methods ........................................................................................................ 45
5.2 Synthetic Procedures ........................................................................................................... 47

5

List of Figures

Figure 1 .............................................................................................................................. 8
Figure 2 ............................................................................................................................ 10
Figure 3 ............................................................................................................................ 17
Figure 4 ............................................................................................................................ 20
Figure 5 ............................................................................................................................ 26
Figure 6 ............................................................................................................................ 36
Figure 7 ............................................................................................................................ 38
Figure 8 ............................................................................................................................ 40
Figure 9 ............................................................................................................................ 42
Figure 10 .......................................................................................................................... 51
Figure 11 .......................................................................................................................... 52
Figure 12 .......................................................................................................................... 53
Figure 13 .......................................................................................................................... 54
Figure 14 .......................................................................................................................... 55
Figure 15 .......................................................................................................................... 56
Figure 16 .......................................................................................................................... 57
Figure 17 .......................................................................................................................... 58

6

List of Schemes

Scheme 1 .......................................................................................................................... 30
Scheme 2 .......................................................................................................................... 32

7

Chapter 1: Thioredoxin Reductase

1.1 Introduction

Thioredoxin (Trx), thioredoxin reductase (TrxR) and NADPH constitute the
thioredoxin system, which functions to maintain redox homeostasis in the cell and is
ubiquitous from Archaea to Homo sapiens.1 Trx is a small, 12 kDa enzyme of the
oxidoreductase family and contains an active site dithiol that serves to catalyze the
reduction of protein disulfides, its active site dithiol being oxidized to a disulfide in the
process (Figure 1). Once oxidized, Trx serves as the native substrate for TrxR, which is a
large, ~70 kDa dimeric protein and is a member of the family of the pyridine nucleotidedisulfide reductases. As such, TrxR can accept reducing equivalents in the form of
NADPH through an enzyme bound FAD cofactor. These electrons then serve to reduce
the N-terminal redox-active disulfide, which passes electrons to the enzyme’s C-terminal
redox center, which eventually transfers the electrons to Trx.

Figure 1. The thioredoxin system, composed of Trx, TrxR, and NADPH.

1

Arnér, E. S. J.; Holmgren, A., Physiological functions of thioredoxin and thioredoxin

reductase. European Journal of Biochemistry 2000, 267 (20), 6102-6109.
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The C-terminal active sites of many high Mr TrxRs contain the motif AA-Cys1X2-AA, where X2 can be either cysteine or, for many higher eukaryotes, selenocysteine
(Sec), the rare, 21st amino acid. TrxR’s C-terminal active site is also somewhat unique in
that, when oxidized, its Cys1/Cys2 or Cys1/Sec2 residues form a vicinal
disulfide/selenosulfide bond during the catalytic cycle.2 Ultimately, it is this C-terminal
disulfide/selenosulfide of TrxR that accepts electrons from the enzyme’s N-terminal
redox center and reduces Trx (see Figure 2).
In the case of mammalian (mTrxR) and rat (TrxR3) orthologs of TrxR, which
contain selenium, it has been shown that the catalytic penultimate Sec residue is essential
for catalysis.3 Specifically, it was showed that when the penultimate Sec residue was
mutated to Cys, the kcat of the mutant enzyme towards Trx was 175-fold lower than in the
wild-type enzyme. Determination of the pH optimum of the mutant enzyme (pH 9)
compared to the wild-type enzyme (pH 7) provided insight into why the Sec residue is so
important for Sec-containing TrxRs. It is hypothesized that the lower pKa of selenols
when compared to thiols (pKa = ~5.3 for Sec, pKa = ~8.3 for Cys) must be important in
the mechanism of action of TrxR, which likely relies on the superior nucleophilicity of a

2

Carugo, O.; Čemažar, M.; Zahariev, S.; Hudáky, I.; Gáspári, Z.; Perczel, A.; Pongor, S.,

Vicinal disulfide turns. Protein Engineering, Design and Selection 2003, 16 (9), 637-639.
3

Zhong, L.; Holmgren, A., Essential Role of Selenium in the Catalytic Activities of

Mammalian Thioredoxin Reductase Revealed by Characterization of Recombinant
Enzymes with Selenocysteine Mutations. Journal of Biological Chemistry 2000, 275
(24), 18121-18128.
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Figure 2. General mechanism of TrxR reduction. In the first step, NADPH transfers
reducing equivalents through an FAD cofactor to the N-terminal redox center of one TrxR
monomer. The resulting thiolate ion then attacks the C-terminal disulfide/selenosulfide (X
= S or Se) of the other TrxR monomer, putting the C-terminal active site in a reduced form
where it can reduce its native substrate, Trx.
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Sec-selenolate anion when compared to a cysteine thiol.
Further studies by Hondal and coworkers elucidated another possible reason that
selenium is essential for catalysis of Sec-containing TrxRs.4 The authors showed that
when the positions of the C-terminal Cys and Sec residues were switched, the catalytic
activity of the mutant enzyme dropped 100-fold. Moreover, they demonstrated that only
Sec-containing TrxRs exhibit hydrogen peroxidase activity. Taken together, their results
provided evidence that the unique chemical properties of the penultimate Sec residue are
important for the mechanism of action of Sec-containing TrxRs, and that selenium is
required for peroxidase activity.
While the various orthologs of TrxR that contain Sec are clearly dependent on the
incorporation of selenium into the enzyme, there are other forms of TrxR in nature that
do not use Sec. Some examples are TrxR from Plasmodium falciparum (PfTrxR)5,
Drosophila melanogaster (DmTrxR)6, and mitochondrial TrxR from Caenorhabditis

4

Eckenroth, B. E.; Lacey, B. M.; Lothrop, A. P.; Harris, K. M.; Hondal, R. J.,

Investigation of the C-Terminal Redox Center of High-Mr Thioredoxin Reductase by
Protein Engineering and Semisynthesis. Biochemistry 2007, 46 (33), 9472-9483.
5

Gilberger, T.-W.; Bergmann, B.; Walter, R. D.; Müller, S., The role of the C-terminus

for catalysis of the large thioredoxin reductase from Plasmodium falciparum. FEBS
Letters 1998, 425 (3), 407-410.
6

Gromer, S.; Johansson, L.; Bauer, H.; Arscott, L. D.; Rauch, S.; Ballou, D. P.; Williams,

C. H.; Schirmer, R. H.; Arnér, E. S. J., Active sites of thioredoxin reductases: Why
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elegans (CeTrxR2)7, which use a C-terminal motif containing a Cys-Cys dyad instead of
Cys-Sec. It is then natural to ask the question: “how do orthologs of TrxR that do not use
Sec maintain competent catalytic activity, given that replacement of Sec for Cys in Seccontaining TrxRs greatly diminishes catalysis?” This question provoked us to investigate
the different mechanisms that Sec-absent TrxRs (termed Cys-containing TrxRs herein)
use to perform their catalytic function. Specifically, the following dissertation outlines
the starting point in an investigation aimed at addressing how CeTrxR2, the Cyscontaining TrxR from Caenorhabditis elegans, managed to evolve without being
dependent on Sec. It focuses on the synthesis and characterization of isosteric peptide
fragments that correspond to the C-terminal active site of CeTrxR2. The project then
transitions into the determination of peptide-disulfide reductase activity of these isosteric
peptide fragments by the N-terminal redox center of CeTrxR2 by the employment of a
truncated version of the enzyme (missing its terminal eight amino acid residues), with
hopes of exposing a significant difference in this activity between the wild type and
mutant peptides.

selenoproteins? Proceedings of the National Academy of Sciences 2003, 100 (22), 1261812623.
7

Lacey, B. M.; Hondal, R. J., Characterization of mitochondrial thioredoxin reductase

from C. elegans. Biochemical and Biophysical Research Communications 2006, 346 (3),
629-636.
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1.2 Previous Work Towards Understanding Cys-Containing TrxRs

The first work aimed at addressing the question of how Cys-containing TrxRs
compete with Sec-containing TrxRs was that of Arnér and coworkers6, where the authors
hypothesized the importance of flanking serine residues towards the catalytic mechanism
of DmTrxR (the C-terminal active site of DmTrxR contains a tetrapeptide -Ser-Cys-CysSer-COOH motif). In this paper, it was shown that mutation of DmTrxR’s C-terminal
active site sequence to either –Gly-Cys-Cys-Gly-COOH or –Ser-Cys-Cys-Gly-COOH
severely lowered the activity of the enzyme towards its native Trx substrate, however the
–Gly-Cys-Cys-Ser-COOH mutation did not lose significant activity. Mutation of any of
these sequences to contain Sec in the penultimate position did not result in any activity
loss, even when both flanking residues were changed to Gly. Finally, mutation of the Cterminal sequence to contain either one or two flanking Asp residues diminished all
activity of the resulting mutant enzymes. The combination of these results led the authors
to hypothesize that the purpose of the flanking Ser residues in DmTrxR is to mediate
thiolate formation during the catalytic cycle via hydrogen bonding, which lowers the
effective pKas of the vicinal C-terminal cysteine residues. This lowering of pKa would, as
a result, increase their ability to perform thiol/disulfide exchange reactions more readily,
as the thiolate anion is the more reactive form of sulfur (compared to a thiol).
These findings can be extended to provide a possible explanation of how the Cyscontaining TrxR from Anopheles gambiae (AgTrxR) is an efficient catalyst without the

13

use of Sec8. AgTrxR contains a C-terminal active site sequence of –Thr-Cys-Cys-SerCOOH and, thus, can also mediate thiolate formation via hydrogen bonds as
hypothesized by Arnér and coworkers.6
In a subsequent study by Arnér and coworkers, it was shown that mutation of
mTrxR’s C-terminal active site (naturally –Gly-Cys-Sec-Gly-COOH) to mimic that of
DmTrxR (with motif –Ser-Cys-Cys-Ser-COOH) caused the mutant enzyme to display
<0.5% of wild-type enzyme activity.9 Using rapid kinetics studies, the authors showed
that the transfer of reducing equivalents from the N-terminal disulfide/dithiol to the Cterminal active site disulfide/dithiol was much slower in the “DmTrxR-mimic” mutant
enzyme compared to the wild-type enzyme. This led to the hypothesis that: “the active
site microenvironment of DmTrxR must have been ‘fine-tuned’ in evolution to support
the Ser-mediated activation of its active site Cys residues; alternatively, the features
supporting such activation have been lost in the case of the mammalian enzyme.” These
studies by Arnér provide strong evidence that the active site microenvironment of Cyscontaining TrxRs is very important to the catalytic efficiency of these enzymes.

8

Bauer, H.; Gromer, S.; Urbani, A.; Schnölzer, M.; Schirmer, R. H.; Müller, H.-M.,

Thioredoxin reductase from the malaria mosquito Anopheles gambiae. European Journal
of Biochemistry 2003, 270 (21), 4272-4281.
9

Johansson, L.; Arscott, L. D.; Ballou, D. P.; Williams Jr, C. H.; Arnér, E. S. J., Studies

of an active site mutant of the selenoprotein thioredoxin reductase: The Ser-Cys-Cys-Ser
motif of the insect orthologue is not sufficient to replace the Cys-Sec dyad in the
mammalian enzyme. Free Radical Biology and Medicine 2006, 41 (4), 649-656.
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Further illustrating the importance of the active site microenvironment of Cyscontaining TrxRs, a study published by Hondal and coworkers demonstrated that when
the C-terminal active site disulfide rings of DmTrxR and CeTrxR2 are mutated via
insertion of Ala residues (in between the Cys residues), the activity of the mutant
enzymes towards Trx dropped significantly (150-300-fold and 90-145-fold for DmTrxR
and CeTrxR2, respectively, depending on how many Ala residues inserted).10 However,
when Sec-containing mouse TrxR (mTrxR3) was mutated via the same procedure, only a
modest 4-6 fold decrease in activity was observed.
These results are important for two reasons. First, they provided evidence for the
hypothesis that Cys-containing TrxRs utilize ring strain6 to perform their catalytic
function, as increasing the ring size of the C-terminal disulfide caused a decrease in
activity to occur. Ring strain is present in this vicinal disulfide bond regardless of
whether the peptide amide backbone adopts a cis or trans conformation.11 In TrxRs that
use Sec, this increase in ring size is not an issue due to the high electrophilicity of
selenium in Sec, which accelerates the C-terminal active site’s acceptance of electrons
from the N-terminal redox center. Second, these results support a hypothesis set forth by
Hondal and coworkers that the C-terminal vicinal disulfide ring of DmTrxR adopts a
strained, cis amide bond conformation during the catalytic cycle to correctly place the

10

Eckenroth, B. E.; Lacey, B. M.; Lothrop, A. P.; Harris, K. M.; Hondal, R. J.,

Investigation of the C-Terminal Redox Center of High-Mr Thioredoxin Reductase by
Protein Engineering and Semisynthesis. Biochemistry 2007, 46 (33), 9472-9483.
11

McMurray, J. (1988) Organic Chemistry, 2nd ed., p 173.
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leaving group Cys thiolate anion near the acid-base catalytic His464¢ residue12, which
facilitates thiol/disulfide exchange13. This second point reiterates the significance of the
C-terminal active site microenvironment for the maintenance of catalytic activity in Cyscontaining TrxRs.
In another study by Hondal and coworkers, the authors demonstrated a major
mechanistic difference between Cys- and Sec-containing TrxRs14. Truncated forms of
mTrxR3, DmTrxR, and CeTrxR2 missing their last eight amino acid residues
(mTrxR3D8, DmTrxRD8, and CeTrxR2D8, respectively) were synthesized and assayed
for activity towards oxidized peptide substrates corresponding to the C-terminal active
sites of each enzyme. The key difference in the peptide substrates assayed was that some
contained the native, intrachain vicinal disulfide/selenosulfide ring, while others
contained an acyclic, interchain disulfide/selenosulfide bond, as shown in Figure 3. In
the case of the interchain peptides, ring strain is relieved and the peptide is free to adopt
energetically-favorable conformations.

12

The ¢ denotes that this residue is present on the other monomer of the dimeric TrxR

complex
13

Eckenroth, B. E.; Rould, M. A.; Hondal, R. J.; Everse, S. J., Structural and

Biochemical Studies Reveal Differences in the Catalytic Mechanisms of Mammalian and
Drosophila melanogaster Thioredoxin Reductases. Biochemistry 2007, 46 (16), 46944705.
14

Lacey, B. M.; Eckenroth, B. E.; Flemer, S.; Hondal, R. J., Selenium in Thioredoxin

Reductase: A Mechanistic Perspective. Biochemistry 2008, 47 (48), 12810-12821.
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Figure 3. Intra- versus interchain peptides corresponding to the C-terminal active sites of
TrxRs. Here, X can be either S or Se. This Figure was adapted from (14).
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The results of assaying each truncated enzyme for reductase activity towards its
corresponding intra- or interchain peptide showed that mTrxR3D8 (a native Seccontaining TrxR) only preferred the intrachain substrate over the interchain substrate by a
factor of 32. However, DmTrxRD8 and CeTrxR2D8 preferred their intrachain substrates
by factors of 1025 and 2267, respectively. This led the authors to hypothesize that “only a
special type of disulfide, a vicinal disulfide with cis amide geometry, can be a substrate
for the truncated Cys-TR because only this type of disulfide has the right geometry to
allow for thiolate attack by [the N-terminal redox center] while at the same time position
the leaving group sulfur atom correctly to accept a proton from the general acid
[His464¢].” The relieving of the ring strain inherent in this cis amide geometry is also
likely to play a role in Cys-containing TrxRs, as mentioned above.6
This hypothesis laid out by Hondal and coworkers was further evaluated in an indepth study of Cys-containing DmTrxR.15 Like in their previous work14, the authors
assayed truncated DmTrxR (DmTrxRD8) for activity against wild-type and mutant
peptide substrates corresponding to its native, C-terminal active site. However, this time
the mutant peptides were varied from the wild-type substrate by increasing the vicinal
disulfide ring size by one unit via the incorporation of homocysteine (hCys) residues,
which contain an extra methylene group in their side chain. Their results showed that

15

Lothrop, A. P.; Snider, G. W.; Flemer, S.; Ruggles, E. L.; Davidson, R. S.; Lamb, A.

L.; Hondal, R. J., Compensating for the Absence of Selenocysteine in High-Molecular
Weight Thioredoxin Reductases: The Electrophilic Activation Hypothesis. Biochemistry
2014, 53 (4), 664-674.
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when the antepenultimate or penultimate Cys residue of the wild-type peptide was
replaced by hCys (increasing the ring size to 9-membered from 8-membered), the Nterminal redox center of DmTrxRD8 reduced the corresponding mutant disulfide ring
slower by factors of 53 and 100, respectively. Interestingly, lipoic acid, a small molecule
containing a strained, 5-membered disulfide ring, was a substrate for DmTrxRD8 with
only 11-fold less activity than the wild-type peptide substrate.
Mutant, full-length enzymes were also constructed where the antepenultimate
(Cys1), penultimate (Cys2), or both Cys residues were replaced by hCys. When Cys1 was
mutated to hCys, the mutant enzyme displayed 240-fold less Trx reductase activity than
the wild-type enzyme. However, when Cys2 or both Cys residues were mutated to hCys,
the mutant enzymes displayed only two-fold and 7-fold less activity than wild-type,
respectively. An additional full-length, mutant enzyme was constructed where two Ala
residues were inserted between the Cys1-Cys2 dyad, and this mutant displayed 300-fold
less activity compared to the wild-type.
The combination of these results lead the authors to put forward a hypothesis that
they term the “electrophilic activation hypothesis,” which is explained in Figure 4. This
hypothesis ultimately takes into account all of the aforementioned data gathered on Cyscontaining TrxRs, specifically DmTrxR, to suggest a mechanism of catalysis. The
hypothesized mechanism demonstrates how any small change in the C-terminal active
site microenvironment – whether it be varying ring strain, the interaction between
specific residues, or effective pKa values of cysteines – drastically affects the catalytic
efficiency of Cys-containing TrxRs.

19

Figure 4. The “electrophilic activation hypothesis” explained. Hondal and coworkers
hypothesize that the C-terminal vicinal disulfide bond of DmTrxR becomes polarized when
the sulfur atom of Cys1 (labeled SL in the Figure) interacts with His464¢H+. As a result, the
sulfur of Cys2 (labeled SE in the Figure) becomes more electrophilic and is the acceptor of
electrons during reduction by the N-terminal redox center (whose Cys-thiolate residue is
shown in green). The leaving group thiolate (SL) is then stabilized and protonated to form
a thiol by the catalytic His464¢H+ residue. This figure was adapted from (15).
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While this hypothesized mechanism is an accurate model for the catalytic action
of DmTrxR, it can be argued that the C-terminal active site microenvironment of
CeTrxR2, which contains a –Gly-Cys-Cys-Gly-COOH motif instead of DmTrxR’s –SerCys-Cys-Ser-COOH sequence, is different than the active site microenvironment of
DmTrxR. It was previously shown that (i) the flanking Ser residues, especially the
ultimate Ser residue, are essential to enzyme function and (ii) replacing these Ser residues
with Gly (as in CeTrxR2) completely diminished Trx reductase activity.6 In addition,
when comparing DmTrxRD8 and CeTrxR2D8 activity towards their native C-terminal
active site peptide 8-mers14, it was shown that CeTrxR2D8 preferred the “intrachain”
substrate (see Figure 3) over the “interchain” substrate twice as much as DmTrxRD8
preferred its own intrachain substrate. These findings give rise to the question of what
different mechanism of action CeTrxR2 uses relative to DmTrxR, considering their
different active site microenvironments yet shared independence of a Sec residue.

21

1.3 Hypothesis: A Key Hydrogen Bond and Vicinal Disulfide Ring Conformation
are Essential to CeTrxR Catalytic Activity

In a 2007 study, Hondal and coworkers presented evidence that the conformation
of the C-terminal vicinal disulfide ring of DmTrxR is important for catalytic activity.13
Their experiments were led by a key observation that TrxR, being in the family of
pyridine nucleotide-disulfide oxidoreductases, can be seen as an extended version of
glutathione reductase (GR) in which its C-terminus is the substrate, contrary to GR where
oxidized glutathione (GSSG) is the substrate. With this idea in mind, the authors
determined which conformations of the peptide fragment –Ser-Cys-Cys-Ser-COOH
(SCCSox), which corresponds to the C-terminal active site of DmTrxR, aligned with
GSSG in the active site binding pocket of the enzyme (determined from X-ray
crystallography). Their results showed that the sulfur atoms of SCCSox aligned with those
of GSSG when the conformation of the Cys-Cys amide bond was cis. Furthermore, this
cis conformation placed the leaving group Cys residue in the right position to accept a
proton from His464¢H+, which should theoretically facilitate thiol-disulfide exchange
between the N-terminal and C-terminal redox centers of DmTrxR.
Given that this active site His residue is conserved among GR16 and all

16

Rietveld, P.; Arscott, L. D.; Berry, A.; Scrutton, N. S.; Deonarain, M. P.; Perham, R.

N.; Williams, C. H., Reductive and oxidative half-reactions of glutathione reductase from
Escherichia coli. Biochemistry 1994, 33 (46), 13888-13895.
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TrxRs17 as an acid-base catalyst, it can be hypothesized that this cis amide bond
conformation is important for how another Cys-containing TrxR, CeTrxR2, performs
catalysis. Due to the lack of flanking Ser residues (as in DmTrxR) to the oxidized CysCys dyad in CeTrxR2, this requirement for specific conformation of active site amino
acid residues is likely even more important for CeTrxR2 than it is for DmTrxR.
Up until this point, it has been reiterated that all Cys-containing TrxRs form a
vicinal disulfide ring between adjacent C-terminal Cys residues. It should be pointed out,
however, that this type of disulfide ring is found in only ~50 protein data bank (PDB)
structures18, and in almost every case it has been shown that they impart an important
enzymatic role.19 In enzymes, this [Cys-Cys]ox dyad is part of a two residue turn that can
fit the molecular constraints of types I, II, VIa, VIb, and VIII β-turns.18 Types VIa and
VIb are unique in that the amide bond between residues (i + 1) and (i + 2) – the amide

17

Gromer, S.; Wessjohann, L. A.; Eubel, J.; Brandt, W., Mutational Studies Confirm the

Catalytic Triad in the Human Selenoenzyme Thioredoxin Reductase Predicted by
Molecular Modeling. ChemBioChem 2006, 7 (11), 1649-1652.
18

Hudáky, I.; Gáspári, Z.; Carugo, O.; Čemažar, M.; Pongor, S.; Perczel, A., Vicinal

disulfide bridge conformers by experimental methods and by ab initio and DFT
molecular computations. Proteins: Structure, Function, and Bioinformatics 2004, 55 (1),
152-168.
19

Avizonis, D. Z.; Farr-Jones, S.; Kosen, P. A.; Basus, V. J., Conformations and

Dynamics of the Essential Cysteinyl-Cysteine Ring Derived from the Acetylcholine
Receptor. Journal of the American Chemical Society 1996, 118 (51), 13031-13039.
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bond between adjacent Cys residues in the case of TrxR – adopts a cis orientation rather
than trans. While isomerization of this amide bond and subsequent β-turn constraint can
occur spontaneously, type VIa and VIb β-turns possess NH(i + 3)-CO(i) hydrogen bonds
that help to stabilize the cis orientation of the (i + 1)-(i + 2) amide bond.20
By integrating the data from Hondal and coworkers13 with the idea of the [CysCys]ox dyad in CeTrxR2 forming a VIa or VIb β-turn (with cis amide geometry), it can be
hypothesized that the NH(i + 3)-CO(i) hydrogen bond stabilizes the cis amide bond
conformation of the b-turn. Removal of this hydrogen bond should favor spontaneous
cis/trans isomerization, allowing the dyad to adopt the multiple other different β-turn
constraints described above. Therefore, if a mutant enzyme of CeTrxR2 is constructed so
that the C-terminal NH(i + 3)-CO(i) hydrogen bond is removed, it would be expected that
catalysis would be greatly diminished because (i) ring strain would be relieved, as the
[Cys-Cys]ox dyad would adopt a lower energy, trans amide bond conformation, and (ii)

20

(i) Ishimoto, B.; Tonan, K.; Ikawa, S.-i., Coupling of intramolecular hydrogen bonding

to the cis-to-trans isomerization of a proline imide bond of small model peptides.
Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy 2000, 56 (1),
201-209. (ii) Sugawara, M.; Tonan, K.; Ikawa, S.-i., Effect of solvent on the cis–trans
conformational equilibrium of a proline imide bond of short model peptides in solution.
Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy 2001, 57 (6),
1305-1316. (iii) Meng, H. Y.; Thomas, K. M.; Lee, A. E.; Zondlo, N. J., Effects of i and
i+3 residue identity on Cis–Trans isomerism of the aromatici+1–prolyli+2 amide bond:
Implications for type VI β-turn formation. Peptide Science 2006, 84 (2), 192-204.

24

isomerization of the (i + 1)-(i + 2) amide bond to the trans conformation would place the
leaving group Cys residue in an incorrect position to accept a proton from His464¢H+.
Removal of the NH(i + 3)-CO(i) hydrogen bond can be accomplished by replacing the
conventional (i + 3) amide bond with an isosteric ester bond. This hypothesis is further
explained in Figure 5.
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Figure 5. (A) In the wild-type CeTrxR2, the NH(i + 3)-CO(i) hydrogen bond (shown in
green) stabilizes the cis amide bond conformation and concomitant type VIa/VIb b-turn,
which places the leaving group Cys sulfur atom (SL) in the correct position to accept a
proton from His464¢H+. (B) If the native (i + 3) amide bond is replaced with an isosteric
ester bond, then this hydrogen bonding cannot occur. As a result, the b-turn will be
disrupted because the trans amide bond conformation will be preferred, which will cause
incorrect positioning of SL towards His464¢H+. This loss of active site cooperation should
result in a substantial decrease in the catalytic abilities of the mutant enzyme.

26

1.4 Plan to Test this Hypothesis

The goal of this work is to first construct peptide 8-mers that correspond to both
the wild-type C-terminal active site of CeTrxR2 (PRTQGCCG) and the mutant Cterminal active site containing an ultimate ester linkage, in which the last amino acid
(glycine) has been replaced by glycolic acid (PRTQGCC(Gac)).21 Next, these peptide
fragments will be assayed for activity towards a truncated version of CeTrxR2 that is
missing its last eight C-terminal amino acid residues (CeTrxRD8).14 This assay will
assess the N-terminal redox center’s ability to reduce the wild-type and mutant peptide
substrates. By comparing the rate of peptide turnover (wild-type versus mutant) by the Nterminal redox center, a conclusion may be drawn as to the importance of the NH(i + 3)CO(i) hydrogen bond for catalysis. If the mutant peptide that cannot form this hydrogen
bond shows no decrease in activity towards CeTrxRD8, then the result will be interpreted
as: the C-terminal active site shows no preference for the conformation of the amide
backbone. However, if a large decrease in activity is observed, then the result will be
interpreted as the opposite: the enzyme does utilize a stabilizing hydrogen bond to adopt
a strained, cis amide bond conformation (and concomitant type VIa/VIb b-turn) that
places the leaving group Cys sulfur atom in the correct position to abstract a proton from
His464¢H+, as described in Figure 5.

21

The mutant 8-mer cannot be synthesized by normal solid phase peptide synthesis

(SPPS) protocol; the retrosynthetic analysis of the mutant peptide is discussed in
Chapter 1.5.
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While it is not the primary focus of this work, the next step towards understanding
the importance of this hydrogen bond will be evaluated by constructing a full length,
mutant enzyme that contains an ultimate ester linkage between the penultimate Cys
residue and glycolic acid. Once constructed, the wild-type and full length enzymes will
be assayed for Trx reductase activity. The results of this assay would be interpreted the
same way as described in the previous paragraph.
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1.5 Retrosynthetic Analysis of Depsipeptide PRTQGCC(Gac)

A retrosynthetic analysis of the mutant depsipeptide containing an ester linkage
between the penultimate cysteine residue and ultimate glycolic acid residue was proposed
(Scheme 1). Starting from commercially available Boc-S-(4-methoxybenzyl)-L-cysteine
(1), we envisioned activating the carboxylic acid residue via a DCC coupling to Nhydroxysuccinimide to form succinimide ester 2. Esterification with glycolic acid using
pyridine and catalytic 4-dimethylaminopyridine (DMAP) would yield the Boc-protected
Cys(Mob)-glycolic acid depside 3. Deprotection of Boc with 1:1 TFA/DCM could give
TFA salt 4. Finally, subsequent protection with Fmoc-OSu would yield the solid phase
peptide synthesis (SPPS)-compatible depside 5, whose carboxyl group could be directly
coupled to 2-chlorotrityl chloride resin. The remaining six amino acids could be attached
via conventional SPPS methods to yield protected depsipeptide 6 linked to 2-chlorotrityl
chloride resin. Finally, simultaneous deprotection and cleavage of 6 from resin22 would
yield mutant depsipeptide PRTQGCC(Gac) containing the necessary vicinal disulfide
ring, which may be reduced by the N-terminal active site of CeTrxRD8.

22

Flemer Jr, S.; Lacey, B. M.; Hondal, R. J., Synthesis of peptide substrates for

mammalian thioredoxin reductase. Journal of Peptide Science 2008, 14 (5), 637-647.
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Scheme 1. Retrosynthetic toward mutant depsipeptide PRTQGCC(Gac).
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Chapter 2: Synthesis of Wild-Type and Mutant Peptides Corresponding to the CTerminal Active Site of CeTrxR

2.1 Synthesis of Fmoc-Protected Cys(Mob)-Glycolic Acid Depside for Solid Phase
Depsipeptide Synthesis

Employing a DCC coupling reaction between starting material 1 and Nhydroxysuccinimide afforded Boc-protected succinimide ester 2 in 96.0% yield (Scheme
2). Esterification with glycolic acid proceeded smoothly in the presence of pyridine and
DMAP to give depside 3 in 96.8% yield. The Boc protecting group was removed via
treatment with 1:1 TFA/DCM, which upon evaporation of solvent followed by repeated
solvation and evaporation by methanol (to remove residual TFA) yielded pure TFA salt 4
(100% yield assumed). TFA salt 4 was used without further purification in a reaction
with Fmoc-Osu under basic conditions in a mixture of H2O/dioxane to afford Fmocprotected depside 5 in 80.4% yield after purification on SiO2.
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Scheme 2. Synthesis of Fmoc-protected depside (5). Reaction conditions: (i) Nhydroxysuccinimide, DCC, ACN, inert atmosphere, 0 °C à r.t., 24 h; (ii) glycolic acid,
pyridine, DMAP, THF, reflux, 24 h; (iii) 1:1 TFA/DCM, 1 h; (iv) Fmoc-OSu, NaHCO3,
H2O/dioxane, 0 °C à r.t., 24 h.
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2.2 Synthesis of Mutant Depsipeptide 8-mer PRTQGCC(Gac) Corresponding
to the C-terminal Active Site of CeTrxR

The initial reaction coupling depside 5 to 2-chlorotrityl chloride resin was carried
out using N-methylmorpholine (NMM) in DCM. Coupling using standard Fmoc
deprotection and HATU activation was employed for peptide elongation. Once the Nterminal proline residue was coupled to the peptide, the a-Fmoc protecting group was
converted to Boc first by treating the resin with 20% piperidine in DMF, followed by
incubation with Boc anhydride and NMM in 1:1 DMF/DCM. The removal of the S-tBu
protecting group from Cys was accomplished by treating the resin with 20% bmercaptoethanol (b-ME) in DMF. The deprotected Cys residue was then activated by
reaction with 2.2’-dithiobis(5-nitropyridine) (DTNP) to form the 5-Npys conjugate.
Deprotection, cyclization, and cleavage of the depsipeptide from the resin was achieved
by incubating the resin with 94:2:2:2 TFA/TIS/H2O/thioanisole. The crude depsipeptide
mixture was precipitated into cold, anhydrous diethyl ether. The resulting solid was spun
into a pellet, dissolved in water, frozen, and lyophilized to yield fully deprotected
PRTQGCC(Gac).
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2.3 Synthesis of Wild Type Peptide 8-mer PRTQGCCG Corresponding to the Cterminal Active Site of CeTrxR

The synthesis of the wild-type peptide PRTQGCCG followed the same procedure
for the synthesis of the mutant peptide PRTQGCC(Gac), except the initial amino acid
coupling to 2-chlorotrityl chloride resin used glycine instead of depside 5. The remaining
7 amino acids were then attached using standard Fmoc deprotection and HATU
activation protocols as described in Chapter 2.2.

34

Chapter 3: Activity of Wild-Type and Mutant Peptide Substrates Towards
Reduction by the N-terminal Redox Center of CeTrxRD8

3.1 Characterization and Assessment of Purity of PRTQGCCG and
PRTQGCC(Gac) Substrates

The mass spectra of the wild-type PRTQGCCG and mutant PRTQGCC(Gac)
peptide substrates synthesized by SPPS are shown in Figure 6. The mass spectrum of
PRTQGCCG shows the main ionization form of PRTQGCCG is the doubly-charged, (M
+ 2H)2+ state with m/z = 410.3, which is attributable to the highly basic a-amine and
arginine-guanidinium functionalities of the peptide substrate. Similarly, in the mass
spectrum of PRTQGCC(Gac), the main ionization state of PRTQGCC(Gac) was (M +
2H)2+ with m/z = 410.8. However, unlike in the mass spectrum of PRTQGCCG where the
peptide m/z = 410.3 was the ion with the greatest intensity, in the mass spectrum of
PRTQGCC(Gac) the ion with the greatest intensity was m/z = 280.3. This m/z value
could not be readily identified.
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Figure 6. (top) Mass spectrum of wild-type peptide PRTQGCCG. The main ionization
form of PRTQGCCG is the doubly-charged, (M + 2H)2+ state with m/z = 410.3. (bottom)
Mass spectrum of mutant peptide PRTQGCC(Gac). Similarly, the main ionization form
of PRTQGCC(Gac) is the doubly-charged, (M + 2H)2+ state with m/z = 410.8.
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In an effort to assess the purity of each substrate, each peptide sample was
subjected to HPLC analysis. Figure 7 shows the HPLC traces of 50 µL injections of 2.44
mM solutions of either PRTQGCCG (red trace) or PRTQGCC(Gac) (blue trace) in 100
mM potassium phosphate buffer, pH 7.0. In both cases, elutions possessing retention
times of less than 5 min corresponded to the elution of phosphate buffer. The HPLC
traces show that each peptide sample contained significant impurities.
The identity of each eluting peak cannot be assumed in routine HPLC
experiments. As such, aliquots of each solution were subjected to HPLC-MS analysis
(data not shown). The extracted ion chromatograms (EIC) monitoring the elution of m/z
values corresponding to either PRTQGCCG or PRTQGCC(Gac) showed that, in each
case, the peptide 8-mers possessed the shortest respective retention times in each
chromatogram, apart from potassium phosphate elution.
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Figure 7. HPLC traces of PRTQGCCG (red) and PRTQGCC(Gac) (blue) samples. HPLC
analyses were conducted by injecting 50 µL of 2.44 mM solutions of either PRTQGCCG
or PRTQGCC(Gac) in 100 mM potassium phosphate buffer, pH 7.0.
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Considering this fact, it was hypothesized that PRTQGCCG (red trace) and
PRTQGCC(Gac) (blue trace) eluted from the HPLC column with retention times of 9.513.3 min and 8.3-11.7 min, respectively, as illustrated in Figure 8. The detector utilized
in this HPLC experiment measured the absorbance at l = 214 nm, rendering Beer’s Law
applicable. As such, it was hypothesized that the effective concentration of PRTQGCCG
in the respective peptide sample was approximately 3 times greater than the effective
concentration of PRTQGCC(Gac), judging from the area of each elution peak.
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Figure 8. Possible elution profiles of PRTQGCCG (red trace) and PRTQGCC(Gac) (blue
trace). Based on HPLC-MS and resulting EIC data, it was hypothesized that PRTQGCCG
eluted from the HPLC column with a retention time of 9.5-13.3 min (red dashed lines),
while PRTQGCC(Gac) eluted from the column at 8.3-11.7 min (blue dashed lines). HPLC
analyses were conducted by injecting 50 µL of 2.44 mM solutions of either PRTQGCCG
or PRTQGCC(Gac) in 100 mM potassium phosphate buffer, pH 7.0.
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3.2 Activity of Substrates Towards Reduction by CeTrxRD8

Assaying both the wild-type and mutant peptide substrates for activity towards a
truncated form of CeTrxR that is missing its last eight amino acid residues (CeTrxRD8)
allows conclusions to be drawn with respect to the N-terminal redox center’s ability to
reduce the vicinal disulfide ring present on each peptide. In the full-length enzyme
possessing these last eight amino acids, this vicinal disulfide ring would be present
between the antepenultimate and penultimate cysteine residues and can be reduced by the
N-terminal redox center of the enzyme. Therefore, if the reductive activity of the mutant
peptide by CeTrxRD8 is lower or higher than that of the wild-type peptide, the result will
be interpreted as both the NH(i+3)-CO(i) hydrogen bond and concomitant type VIa bturn conformational preference being either important or not important for catalytic
activity of CeTrxR.
The CeTrxRD8 reductase activity towards both the wild-type and mutant peptide
substrates is shown in a Michaelis-Menten plot in Figure 9. The Figure shows a dramatic
difference in the activity of CeTrxRD8 towards each substrate. While the activity of
CeTrxRD8 towards the wild-type peptide PRTQGCCG steadily increases with increasing
peptide concentration, the opposite is true for the mutant depsipeptide PRTQGCC(Gac):
the truncated enzyme’s activity towards the mutant substrate is identical to the inherent
background NADPH oxidase activity of CeTrxRD8.
While these data seem to support the central hypothesis that the NH(i+3)-CO(i)
hydrogen bond and concomitant type VIa b-turn conformational preference play a vital
role in catalysis of CeTrx2, this result must be taken with caution. In Figure 7 and
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Figure 9.

Activity of CeTrxRD8 towards PRTQGCCG (wild-type, blue bars) and

PRTQGCC(Gac) (mutant, red bars) peptide substrates. The activity was monitored by
consumption of NADPH via a decrease in absorbance at 340 nm. Reaction mixtures
contained 100 mM potassium phosphate, pH 7.0, 1 mM EDTA, 200 µM NADPH, 0.253.00 mM peptide, and 100 nM CeTrxRD8. The wild-type peptide is represented by the red
open circles (PRTQGCCG), blue closed squares represent the mutant peptide
(PRTQGCC(Gac)).
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Figure 8, attention was brought to the fact that the peptide samples used in this assay
were (i) not entirely pure and (ii) possessed what seemed to be different effective
concentrations of the correct peptide substrates. Therefore, the possibility arises that this
decrease in activity may be attributed to there being less peptide substrate present in the
mutant peptide assay. In further studies, the crude peptide samples must be purified in
order to rule this possibility out.

43

Chapter 4: Summary and Future Directions

In summary, wild-type (PRTQGCCG) and mutant (PRTQGCC(Gac)) peptide
substrates were synthesized and their purity was assessed. Each peptide sample contained
significant impurities as shown in the HPLC traces in Figure 7. In addition, each peptide
sample may have possessed unequal effective concentrations of the relevant peptide
substrate to be reduced by the truncated form of CeTrxR2 missing its last 8 amino acid
residues (CeTrx2D8). When the peptide substrates were assayed against CeTrx2D8, the
mutant peptide displayed no detectable activity. This result may support the hypothesis
that the NH(i+3)-CO(i) hydrogen bond and concomitant type VIa b-turn conformational
preference play a vital role in catalysis of CeTrx2.
In future studies, the peptide substrates must be purified before they are assayed
for activity against CeTrx2D8. In addition, a full length, mutant enzyme that contains an
ultimate ester linkage between the penultimate Cys residue and glycolic acid must be
constructed. The wild-type and full length mutant enzymes should be assayed for Trx
reductase activity.
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Chapter 5: Experimental Procedures

5.1 Materials and Methods

Unless otherwise stated, all non-aqueous reactions were carried out in either ovendried or flame-dried glassware. All commercially available starting materials were
purchased from Aldrich, Fischer Scientific, or Acros Organics, and used as received.
Analytical TLC was performed on Millipore TLC Silica gel 60 F254 silica gel plates with
UV indicator. Visualization was accomplished by irradiation under a 254 nm UV lamp or
stained with either an aqueous solution of CAM, KMnO4, or phosphomolybdic acid.
Flash chromatography was performed using a forced flow of the indicated solvent system
on Select Scientific Silica Gel (32-63 particle size). Removal of solvents was
accomplished on a Büchi R-114 rotary evaporator and compounds were further dried
under a high vacuum line.
All 1H data was conducted at ambient temperatures and recorded on a Varian
UnityInova (500 MHz) or Bruker ARX (500 MHz) spectrometer. 13C NMR spectra were
recorded on a Bruker ARX (125 MHz) spectrometer. Chemical shifts are reported
relative to chloroform (d = 7.27) for 1H spectra and chloroform (d = 77.2) for 13C
spectra. Data are reported as follows: chemical shift, multiplicity (s = singlet, d = doublet,
t = triplet, q = quartet, p = pentet, br = broad, m = multiplet), coupling constants (Hz),
and number of protons. Direct infusion mass spectrometry was executed using an ABI
Sciex 4000QTrap Pro LCMS in positive-ESI mode. Liquid chromatography-mass
spectrometry was executed using an ABI Sciex 4000QTrap Pro LCMS equipped with a
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C18 column in positive-ESI mode.
All analytical HPLC chromatography was carried out on a Shimadzu analytical
HPLC system which utilized LC-10AD pumps, a SPD-10A UV-Vis detector, and a SCL10A controller. A Shimadzu Shim-packTM VP-ODS C18 analytical column (4.6 µm
pore size, 150 × 4.6 mm) was used in these separations. Beginning with 100% Buffer A,
a 1.4 mL/min gradient elution increase of 1% Buffer B/min for 50 min was used for all
peptide chromatograms (Buffer A = 0.1% TFA/H2O; Buffer B = 0.1% TFA/ACN).
Peptide elution profiles were detected at 214 nm and 254 nm.
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5.2 Synthetic Procedures

Synthesis of 2.
In an oven dried flask, 1 (10.07 g, 29.49 mmol) was dissolved in THF (120 mL)
under an atmosphere of N2. N-hydroxysuccinimide (3.77 g, 32.76 mmol) was added and
the solution was cooled to 4 °C. Once cooled, DCC (6.77 g, 32.81 mmol) was added and
the reaction was allowed to proceed at 4 °C for 1 h and then at room temperature for an
additional 5 h. Thereupon, the reaction mixture was filtered and the filtrate was
evaporated in vacuo. The resulting residue was dissolved in 200 mL dichloromethane and
transferred to a separatory funnel. The organic layer was extracted with aqueous saturated
NaHCO3 solution (1 x 100 mL) and H2O (1 x 100 mL), then washed with brine (1 x 100
mL). The organic layer was dried over MgSO4, filtered, and concentrated in vacuo. The
crude product was recrystallized from Et2O. The crystals were washed with cold Et2O (6
x 15 mL) and dried in vacuo to yield 2 (12.41 g, 96.0%) as a white, crystalline solid.
Rf = 0.27 (1:1 hexane/ethyl acetate). 1H NMR (500 MHz, Chloroform-d) δ 11.11
(br s, 1H), 7.21 (d, J = 8.7 Hz, 2H), 6.83 (d, J = 8.6 Hz, 2H), 5.33 (d, J = 8.0 Hz, 1H),
4.54 (dd, J = 7.1, 6.6 Hz, 1H), 3.78 (s, 3H), 3.69 (s, 2H), 2.91 (dd, J = 14.1, 5.9 Hz, 1H),
2.85 (dd, J = 14.1, 5.9 Hz, 1H), 1.45 (s, 9H). 13C NMR (125 MHz, CDCl3) δ 175.81,
158.76, 155.49, 130.07, 129.54, 114.03, 80.55, 77.31, 77.06, 76.80, 55.26, 52.97, 36.09,
33.19, 28.31. MS (pos APCI) m/z 339.9 [(M – Boc + H)+, calculated for C20H26N2O7S:
438.15].
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Synthesis of 3.
In an oven dried flask, glycolic acid (1.25 g, 16.42 mmol) was dissolved in THF
(87 mL) under an atmosphere of Ar. Then pyridine (1107 µL, 13.68 mmol), DMAP (187
mg, 1.53 mmol), and 2 (6.02 g, 13.68 mmol) were added and the reaction was heated to
66 °C and subsequently refluxed for 24 h. The reaction mixture was concentrated in
vacuo. The resulting residue was dissolved in ethyl acetate (80 mL) and transferred to a
separatory funnel with 10% aqueous citric acid solution (80 mL). The organic layer was
separated and extracted with aqueous saturated NaHCO3 solution (1 x 80 mL). The
combined aqueous layers were acidified to pH 2.5 with 12 N HCl. The acidified aqueous
layer was back extracted with ethyl acetate (2 x 80 mL). The combined organic layers
were washed with brine (1 x 150 mL), dried over MgSO4, filtered, and concentrated in
vacuo to yield 3 (5.29 g, 96.8%) as a white-yellow foam, which was immediately used in
the synthesis of 5.
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Synthesis of 5.
In a round bottom flask, 3 (1.03 g, 2.57 mmol) was dissolved in 1:1 TFA/DCM
(25 mL) and the mixture was stirred for 1 h at room temperature with ventilation. Upon
reaction completion (monitored by TLC, 9:1 acetone/MeOH), the solvent was
concentrated in vacuo. The resulting residue was repeatedly dissolved in methanol with
subsequent concentration in vacuo (to remove residual TFA) to yield 4 (100% yield
assumed) as an orange foam, which was used without further purification in subsequent
steps.
In a round bottom flask, 4 (2.57 mmol assumed from previous step) was dissolved
in 1,4-dioxane (7.5 mL) and a solution of NaHCO3 (647 mg, 7.7 mmol) in H2O (12.5
mL) was added to the mixture. The solution was cooled to 4 °C and a solution of FmocOSu (1.56 g, 4.62 mmol) in 1,4-dioxane (5 mL) was added dropwise over 30 min via
syringe. The mixture was stirred for 1 h at 4 °C. After 1 h, additional 1,4-dioxane (25
mL) was added to fully dissolve all solids. The pH of the reaction mixture was adjusted
to 8 via the addition of aqueous saturated NaHCO3 solution. Once these conditions were
achieved, the mixture was stirred for 24 h at r.t. The mixture was transferred to a
separatory funnel with H2O (100 mL). The aqueous layer was extracted with ethyl acetate
(2 x 100 mL). The organic layer was back extracted with aqueous saturated NaHCO3
solution (1 x 100 mL). The combined aqueous layers were acidified to a pH of 1 with 12
N HCl and extracted with ethyl acetate (3 x 100 mL). The combined organic layers were
dried over MgSO4 and concentrated in vacuo. The resulting residue was purified via flash
chromatography (100% dichloromethane à 9:1 dichloromethane/MeOH) to yield 5 (1.16
g, 80.4%) as a white solid.

49

Rf = 0.20 (9:1 dichloromethane/MeOH). 1H NMR (500 MHz, Chloroform-d) δ
7.76 (d, J = 7.2 Hz, 2H), 7.60 (t, J = 6.6 Hz, 2H), 7.39 (t, J = 7.4 Hz, 2H), 7.31 (t, J = 7.4
Hz, 2H), 7.20 (d, J = 8.3 Hz, 2H), 6.83 (d, J = 8.4 Hz, 2H), 5.55 (d, J = 7.8 Hz, 1H), 4.72
(m, 2H), 4.64 (m, 1H), 4.41 (d, J = 7.0 Hz, 2H), 4.23 (t, J = 6.9 Hz, 1H), 3.76 (s, 3H),
3.69 (s, 2H), 2.98 (dd, J = 14.0, 6.5 Hz 1H), 2.86 (dd, J = 14.0, 6.5 Hz, 1H) (CO2H not
observed). 13C NMR (125 MHz, CDCl3) δ 170.96, 170.39, 158.97, 156.11, 143.76,
141.46, 130.20, 129.48, 127.92, 127.26, 125.24, 120.17, 114.21, 77.41, 77.16, 76.91,
67.54, 60.99, 55.41, 53.50, 47.22, 36.22, 33.31. MS (pos ESI) m/z 522.3 [(M + H)+,
calculated for C28H27NO7S: 521.15].
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Figure 10. 1H NMR spectrum of 1 in CDCl3.
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Figure 11. 13C NMR spectrum of 1 in CDCl3.
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Figure 12. 1H NMR spectrum of 2 in CDCl3.
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Figure 13. 13C NMR spectrum of 2 in CDCl3.
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Figure 14. Positive ESI mass spectrum of 2.
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Figure 15. 1H NMR spectrum of 5 in CDCl3.
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Figure 16. 13C NMR spectrum of 5 in CDCl3.
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Figure 17. Positive ESI mass spectrum of 5.
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